What to Expect with Bispecific Therapy
Recent advances in medical research have enabled the development of bispecific therapies, offering a dual-targeted approach to enhance precision and efficacy in cancer treatment. Bispecific antibodies present a novel therapeutic option for patients whose cancers may not respond well to conventional treatments. By engaging both the immune system and the tumor directly, this therapy provides a targeted approach that could improve outcomes in challenging cases.
How is bispecific antibody therapy administered?
At Texas Oncology, injections or infusions for bispecific therapy are delivered in an outpatient infusion center. This treatment may utilize step-up dosing, gradually increasing the amount of medication given in an effort to mitigate side effects. After the initial step-up dosing is completed, bispecific therapies may continue at regularly scheduled dosing intervals or as maintenance therapy.
What are the side effects of bispecific therapy?
Like all cancer treatments, bispecific therapy may come with some side effects, including:
Less common but serious side effects include Cytokine Release Syndrome (CRS) (a temporary immune reaction that can cause fever, low blood pressure or difficulty breathing), neurological symptoms, infections, and low blood counts.
If you have questions about bispecific therapy or its potential side effects, please consult your provider.